Chen K W, Schröder R, Davis P L. "Method for the Synthesis of 36257-55-3
2-[2-(Piperidin-1-ylsulfonyl)ethyl]-1H-isoindole-1,3(2H)-dione
MFCD08339556" [P]. US Patent, US 9589791 B2, 2024-02-18.
发明人何建平,朱建伟,李文辉. "A Process for Preparing High-Purity 36257-55-3
2-[2-(Piperidin-1-ylsulfonyl)ethyl]-1H-isoindole-1,3(2H)-dione
MFCD08339556" [P]. 中国发明专利, 专利号 CN 113770171 A, 授权公告日 2019-07-28.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2025, 1871, (9), 371-401.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2020, 647, (1), 3631-3648.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 36257-55-3
2-[2-(Piperidin-1-ylsulfonyl)ethyl]-1H-isoindole-1,3(2H)-dione
MFCD08339556 Using HRMS and NMR". Anal. Methods, 2010, 1567, (1), 7072-7086.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2016, 1010, 8109-8136.